BNP Paribas Asset Management
FOLD

BNP Paribas Asset Management’s Amicus Therapeutics FOLD Stock Holding History

BNP Paribas Asset Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,729
Closed -$68.4K – 2288
2026
Q1 		$68.4K Buy
4,729
+1,520
+47% +$21.8K ﹤0.01% 1630
2025
Q4 		$46K Buy
3,209
+1,441
+82% +$14.2K ﹤0.01% 1687
2025
Q3 		$14K Sell
1,768
-217
-11% -$1.54K ﹤0.01% 1520
2025
Q2 		$11K Buy
+1,985
New +$12.8K ﹤0.01% 1733
2021
Q1 		– Sell
-872,803
Closed -$20.2M – 854
2020
Q4 		$20.2M Sell
872,803
-687,830
-44% -$14.1M 0.09% 251
2020
Q3 		$22M Buy
1,560,633
+202,088
+15% +$2.95M 0.13% 203
2020
Q2 		$20.5M Sell
1,358,545
-508,588
-27% -$6.2M 0.14% 184
2020
Q1 		$17.3M Sell
1,867,133
-249,332
-12% -$2.37M 0.15% 187
2019
Q4 		$20.6M Buy
2,116,465
+455,637
+27% +$4.17M 0.14% 202
2019
Q3 		$13.3M Buy
1,660,828
+20,593
+1% +$224K 0.1% 254
2019
Q2 		$20.5M Buy
1,640,235
+132,642
+9% +$1.68M 0.17% 169
2019
Q1 		$20.5M Sell
1,507,593
-5,730
-0.4% -$70K 0.17% 170
2018
Q4 		$14M Sell
1,513,323
-34,158
-2% -$375K 0.13% 223
2018
Q3 		$18.7M Buy
1,547,481
+463,448
+43% +$6.48M 0.14% 204
2018
Q2 		$16.9M Buy
1,084,033
+171,937
+19% +$2.6M 0.14% 196
2018
Q1 		$13.7M Buy
+912,096
New +$13.9M 0.12% 245

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

BNP Paribas Asset Management's FOLD Position: Q2 2026 in Review

BNP Paribas Asset Management sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 4,729 shares — an estimated $68.4K sold.

BNP Paribas Asset Management first reported a position in FOLD in Q1 2018 and held it in 16 quarters. The position peaked at $22M in Q3 2020. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • BNP Paribas Asset Management reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • BNP Paribas Asset Management sold 4,729 Amicus Therapeutics shares in Q2 2026, an estimated $68.4K.
  • BNP Paribas Asset Management first reported a position in Amicus Therapeutics in Q1 2018 and held it in 16 quarters.
  • BNP Paribas Asset Management's Amicus Therapeutics position peaked at $22M in Q3 2020.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.